Valproic Acid

Valproic acid has multiple mechanisms of action ^{[1, 3]}:

1. Enhancement of GABAergic neurotransmission: Valproate increases brain GABA levels by inhibiting GABA transaminase (the enzyme that breaks down GABA) and possibly by enhancing GABA synthesis. GABA is the brain's primary inhibitory neurotransmitter ^{[1, 3]}.

2. Voltage-gated sodium channel blockade: Like phenytoin and carbamazepine, valproate blocks sustained repetitive neuronal firing by modulating sodium channels, though this effect is less potent ^{[1, 3]}.

3. T-type calcium channel blockade: Valproate reduces T-type calcium currents in thalamic neurons, which is thought to contribute to its efficacy in absence seizures ^{[1, 3]}.

4. Epigenetic effects: Valproate is a histone deacetylase (HDAC) inhibitor, which may contribute to its mood-stabilizing properties and is being investigated in cancer research ^{[3, 5]}.

For bipolar disorder, valproate is one of the most effective treatments for acute mania and was one of the first medications FDA-approved for this indication. Its antimanic efficacy is well-established from the pivotal trials by Bowden et al. ^{[5, 6]}. However, unlike lamotrigine, it has limited evidence for preventing bipolar depression ^{[5, 6]}.

Valproate is considered a broad-spectrum anticonvulsant, effective against virtually all seizure types including focal seizures, generalized tonic-clonic seizures, absence seizures, and myoclonic seizures ^{[1, 3]}.

Week 1: Starting dose depends on indication and urgency. GI side effects (nausea, vomiting, diarrhea) are common initially, especially with valproic acid (Depakene). Divalproex sodium (Depakote) is better tolerated due to enteric coating ^[1].

Weeks 1-4: For acute mania, loading strategies can achieve therapeutic levels within 1-2 days. Antimanic effects may begin within 3-5 days. Sedation, tremor, and GI effects are common. Baseline labs (CBC, liver function, amylase/lipase) should have been obtained ^{[1, 5]}.

Weeks 4-12: Dose stabilized based on blood levels (target 50-125 mcg/mL). Weight gain, hair thinning, and tremor may develop. Periodic liver function tests and drug levels are needed ^[1].

Long-term: Weight gain averages 5-10 kg and is a major concern. Hair loss (usually reversible) occurs in ~10% of patients. Tremor may persist. Monitor CBC, liver function, and drug levels periodically. Polycystic ovary syndrome (PCOS) risk is increased in women ^{[1, 7]}.

Divalproex sodium (Depakote) should be swallowed whole — do not crush or chew the enteric-coated tablets. Can be taken with food to reduce GI side effects. Depakote Sprinkle Capsules can be opened and sprinkled on soft food ^[1].

Alcohol: Alcohol should be avoided with valproic acid. Both are hepatotoxic and CNS depressants. The combination increases sedation and may increase liver damage risk. Given the boxed warning for hepatotoxicity, alcohol avoidance is particularly important ^[1].

Grapefruit: No significant interaction ^[1].

Caffeine: No significant interaction ^[1].

Carbonated beverages: Do not mix valproic acid syrup with carbonated beverages — it can cause irritation and early release of the drug ^[1].

Dosing varies by indication and formulation ^[1]:

Epilepsy (adults): Start 10-15 mg/kg/day in divided doses. Increase by 5-10 mg/kg/day weekly. Target trough level: 50-100 mcg/mL. Maximum: 60 mg/kg/day ^[1].

Bipolar Mania (divalproex): Start 750 mg/day in divided doses. Increase rapidly to achieve trough levels of 50-125 mcg/mL. Rapid loading: 20-30 mg/kg/day may achieve therapeutic levels in 1-2 days for acute mania ^{[1, 5]}.

Migraine prevention: Start 250 mg twice daily (Depakote) or 500 mg/day (Depakote ER). Target: 500-1000 mg/day. Maximum recommended: 1000 mg/day ^[1].

Depakote ER vs DR: ER bioavailability is ~89% of DR. When converting, ER dose should be 8-20% higher than DR dose ^[1].

Monitoring: Trough valproic acid level, CBC with platelets, liver function tests at baseline and periodically. Ammonia level if encephalopathy symptoms develop ^[1].

Hepatic impairment: Contraindicated in significant hepatic disease. Use with extreme caution in mild impairment ^[1].

Generic divalproex sodium and valproic acid are widely available and cost approximately $15-40/month compared to $200-500/month for brand-name Depakote ^[1].

Pharmacy discount programs: Generic divalproex DR (delayed-release) tablets are available for $12-25/month through discount programs. The ER formulation is slightly more expensive ^[1].

Patient assistance programs: AbbVie (manufacturer of Depakote) offers patient assistance through AbbVie Patient Assistance Foundation ^[1].

Insurance: Generic divalproex is Tier 1 on most formularies. Prior authorization is not typically required ^[1].

Pregnancy: Valproic acid is strongly contraindicated in pregnancy when alternatives exist. It has one of the highest teratogenicity rates of any medication ^{[1, 8, 9]}: - Major malformation rate: 6-11% (vs 2-3% background rate) - Neural tube defects (spina bifida): 1-2% (10-20x background rate) - Cardiac malformations, cleft palate, craniosynostosis, limb defects also increased - Children exposed in utero have lower IQ scores (average 8-9 points lower) and increased rates of autism spectrum disorder

The FDA boxed warning states valproate should not be given to women of childbearing potential unless essential. If unavoidable, use effective contraception and the lowest effective dose. High-dose folate (4-5 mg/day) is recommended but does not fully prevent neural tube defects ^{[1, 8, 9]}.

Breastfeeding: Valproate is excreted in breast milk at low levels (1-10% of maternal serum levels). Breastfeeding is generally considered acceptable with monitoring, but discuss with the prescriber ^[10].

Bioequivalence: Generic divalproex sodium DR and ER tablets are FDA AB-rated as bioequivalent to brand Depakote ^[1].

Clinical equivalence: Generic formulations have demonstrated equivalent blood levels and efficacy. Therapeutic drug monitoring is recommended regardless of brand or generic use ^[1].

Formulation options: Generic available as divalproex DR tablets, ER tablets, sprinkle capsules; valproic acid capsules and solution ^[1].

Cost: Brand Depakote: $200-500/month. Generic divalproex: $15-40/month ^[1].